Home

Elevance Health, Inc. Common Stock (ELV)

375.40
-41.29 (-9.91%)
NYSE · Last Trade: May 13th, 8:01 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close416.69
Open399.78
Bid377.00
Ask381.00
Day's Range374.78 - 399.78
52 Week Range362.21 - 567.26
Volume3,574,950
Market Cap87.34B
PE Ratio (TTM)-
EPS (TTM)-
Dividend & Yield6.840 (1.82%)
1 Month Average Volume1,562,736

Chart

News & Press Releases

ELV Shareholder Alert: Robbins LLP Informs Investors of the Elevance Health, Inc. Class Action Lawsuit
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · May 13, 2025
ELV Shareholder Alert: Robbins LLP Informs Investors of the Elevance Health, Inc. Class Action Lawsuit
SAN DIEGO, CA - May 13, 2025 ( NEWMEDIAWIRE ) - Robbins LLP informs stockholders that a class action was filed on behalf of all purchasers of Elevance Health, Inc. (NYSE: ELV) common stock between April 18, 2024 and October 16, 2024. Elevance is a healthcare company that, among other things, provides health insurance plans to a variety of markets.
Via TheNewswire.com · May 13, 2025
ELV Investors Have Opportunity to Lead Elevance Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elevance Health, Inc. (“Elevance” or “the Company”) (NYSE: ELV) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
By The Schall Law Firm · Via Business Wire · May 13, 2025
ELV BREAKING NEWS: Elevance Health, Inc. Stock Plummets 11% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NYSE:ELV)
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential violations of the federal securities laws.
By Bleichmar Fonti & Auld LLP · Via Business Wire · May 13, 2025
Here's How Much $100 Invested In Elevance Health 15 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · May 13, 2025
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Elevance Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - ELV
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
By Pomerantz LLP · Via GlobeNewswire · May 13, 2025
Rosen Law Firm Urges Elevance Health, Inc. (NYSE: ELV) Stockholders to Contact the Firm for Information About Their Rights
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024, and October 16, 2024. Elevance describes itself as a “healthcare company that provides health insurance plans to a variety of markets.”
By The Rosen Law Firm, P.A. · Via Business Wire · May 13, 2025
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Elevance Health
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV) and reminds investors of the July 11, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
By Faruqi & Faruqi, LLP · Via Business Wire · May 13, 2025
Wall Street Climbs As Inflation Cools, Nasdaq 100 Hits 10-Week Highsbenzinga.com
U.S. stocks edged higher as April inflation cooled more than expected. Nasdaq 100 surged, led by semis and financials.
Via Benzinga · May 13, 2025
Humana, Elevance, Aetna Face DOJ Lawsuit Over Illegal Kickback Scheme, Discrimination Against Disabled Peoplebenzinga.com
The lawsuit alleges that from 2016 through at least 2021, the insurers paid hundreds of millions of dollars in illegal kickbacks to brokers.
Via Benzinga · May 5, 2025
Here's How Much $1000 Invested In Elevance Health 20 Years Ago Would Be Worth Todaybenzinga.com
Via Benzinga · May 1, 2025
Kroger: This Must-Own Staples Stock Thrives in Every Market
Kroger is a best-of-breed supermarket operator that has margin expansion during high inflation and a revenue jump during recessions as consumer eat more at home
Via MarketBeat · April 29, 2025
Humana Earnings: What To Look For From HUM
Health insurance company Humana (NYSE:HUM) will be reporting results tomorrow before market hours. Here’s what you need to know.
Via StockStory · April 29, 2025
These S&P500 stocks are moving in today's sessionchartmill.com
Curious about the top performers within the S&P500 index one hour before the close of the markets on Monday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via Chartmill · April 28, 2025
What To Expect From HCA Healthcare’s (HCA) Q1 Earnings
Hospital operator HCA Healthcare (NYSE:HCA) will be reporting earnings tomorrow before market open. Here’s what you need to know.
Via StockStory · April 24, 2025
Centene (CNC) Q1 Earnings Report Preview: What To Look For
Health coverage company Centene (NYSE:CNC) will be announcing earnings results tomorrow before market hours. Here’s what to expect.
Via StockStory · April 24, 2025
Encompass Health (EHC) Reports Q1: Everything You Need To Know Ahead Of Earnings
Health care services provider Encompass Health (NYSE:EHC) will be reporting results tomorrow after market close. Here’s what you need to know.
Via StockStory · April 23, 2025
Despite Medicaid Pressure, Elevance Health Delivers Strong Q1 Performance, Reiterates Profit Outlookbenzinga.com
Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.
Via Benzinga · April 22, 2025
Top S&P500 movers in Tuesday's pre-market sessionchartmill.com
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
Via Chartmill · April 22, 2025
Earnings To Watch: Molina Healthcare (MOH) Reports Q1 Results Tomorrow
Healthcare insurance company Molina Healthcare (NYSE:MOH) will be reporting earnings tomorrow after market close. Here’s what investors should know.
Via StockStory · April 22, 2025
Chemed (CHE) Reports Earnings Tomorrow: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what you need to know.
Via StockStory · April 22, 2025
Elevance Health Reports Upbeat Q1 Earnings, Reaffirms Full-Year Guidance: But Retail’s Unimpressedstocktwits.com
The company affirmed its full year adjusted diluted earnings per share guidance of $34.15 to $34.85.
Via Stocktwits · April 22, 2025
Elevance Health’s (NYSE:ELV) Q1 Sales Top Estimates
Health insurance provider Elevance Health (NYSE:EVH) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 14.5% year on year to $48.77 billion. Its non-GAAP profit of $11.97 per share was 4.3% above analysts’ consensus estimates.
Via StockStory · April 22, 2025
Elevance Health Reports First Quarter 2025 Results
Elevance Health, Inc. (NYSE: ELV) reported first quarter 2025 results.
By Elevance Health, Inc. · Via Business Wire · April 22, 2025
Earnings Scheduled For April 22, 2025benzinga.com
Via Benzinga · April 22, 2025